Meet
Versius Plus
The next generation in surgical robotics.
Versius Plus is a surgical robot developed and engineered for versatility and adaptability, driven by a digital ecosystem embedded at its core.
Now FDA 510(k) cleared for Cholecystectomy.
A defining moment in robotic-assisted surgery – Versius reaches 45,000 cases worldwide as the second most utilized robotic surgical platform globally.
Freedom to Access By Design - Versius Plus
Versius Plus is designed to expand access to robotic surgery across all care settings
Adaptable
Owing to its compact, modular design, Versius Plus moves easily between departments and operating rooms – with no dedicated OR required. Hospitals can seamlessly switch between robotic and non-robotic procedures in the same space. Surgeons benefit from flexible port placement, choosing the setup that best fits their patient and their technique.
Versatile
Through design and technology, Versius Plus delivers the precision and efficiency surgeons demand. Its integrated fluorescence visualization system, vLimeLite, enables real-time ICG imaging, delivering enhanced visual information. With a full surgical toolkit, Versius Plus is ready to transform surgical experience in the OR.
Digitally Driven
The Versius Plus ecosystem puts data at your fingertips through two dedicated apps for surgeons and hospital teams. Versius Connect provides near-real-time procedural logbook for surgeons, while Versius Team offers live dashboard tracking usage, case volume, and system efficiency. Together, these tools help optimize your robotic program with clear insights.
Learn more about Versius Plus
Full suite of instruments
Full suite of instruments
Versius Plus is now able to empower surgeons, delivering multi-functional use across numerous procedures. Versius Plus provides a full range of instruments, with fully articulated standard instruments to enhance surgical precision.
Enhanced vision system
- vLimeLite, an integrated fluorescence visualization system, with multiple modes
- Powerful vision control with automatic brightness
- 26", 3DHD screen to enhance visualization
Digitally driven ecosystem
Digitally driven ecosystem
- New features and performance improvements delivered through software
- Real-time, data-driven insights via Versius Connect and Versius Team
- Clinical and operational monitoring
This 510(k) clearance represents an exciting new chapter for CMR Surgical as we introduce Versius Plus to the U.S. market.
Massimillano Colella
Chief Executive Officer at CMR Surgical
Publications
Ready to experience Versius Plus? Connect with our team today.
News
The CMR Surgical news page keeps you in the know, from updates on Versius and its developments, to the latest in robotic surgery news. We also celebrate our team, welcome new appointments and showcase our corporate wins.
CMR Surgical Strengthens Senior Team
September 3, 2024
CMR Surgical has appointed Markus Bauman as Chief Legal & Business Affairs Officer and will join CMR’s executive leadership team. Michelle Paknad has been appointed ...
Disclaimer:
Versius Plus is a Robotic-Assisted Surgical Device intended to assist in the precise and accurate control of Versius Surgical endoscopic instruments and is indicated in the U.S. for adult patients 22 years of age and older, eligible for soft tissue minimal access surgery, for cholecystectomy. For full product and safety information, please refer to Important Safety Information.
Versius Plus is 510k cleared by FDA and is approved for sale in the United States.
Versius Plus is part of a Versius ecosystem comprised of the Versius Surgical System, the EIZO CuratOR product, the vLimeLite visualization system, and a suite of electrosurgical and nonelectrosurgical instruments in the United States.
CMR Surgical, the CMR Surgical logo, vLimeLite and Versius are trademarks or registered trademarks of CMR Surgical in the UK and other jurisdictions. EIZO, the EIZO logo, and CuratOR are trademarks or registered trademarks of EIZO Corporation in Japan and other countries Indocyanine green (ICG) is a drug and is not provided by CMR Surgical and must be independently sourced by the customer. The approval status of the drug may vary by country.
The Versius System vLimeLite Instructions for Use, including the approved indications, contraindications and warnings can be found in the product labeling supplied with each Versius Plus System. The Ultrasonic Dissector is not approved for sale in the United States. Versius and its associated products are commercially available in certain geographies. Regulatory requirements of individual countries and regions will determine approval, clearance, or market availability. Please contact your local CMR Surgical representative for product availability in your region. Refer to the product-specific user manual for indications, contraindications, warnings, and other product information. The information is correct at the time of publication of this press release.